SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-12-038275
Filing Date
2012-06-28
Accepted
2012-06-28 14:10:39
Documents
1
Period of Report
2012-06-20

Document Format Files

Seq Description Document Type Size
1 BRYCE F3 rrd349642.html 3  
1 BRYCE F3 rrd349642.xml 3 1541
  Complete submission text file 0001181431-12-038275.txt   3066
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Issuer) CIK: 0001401667 (see all company filings)

IRS No.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PUMA BIOTECHNOLOGY, INC. 10880 WILSHIRE BOULEVARD, SUITE 2150 LOS ANGELES CA 90024
Business Address
BRYCE RICHARD PAUL (Reporting) CIK: 0001553037 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-52811 | Film No.: 12932126